GcMAF
Immuno Biotech financial chief found guilty of money laundering
February 12, 2019Manufacturing and Production David Noakes, Dawson-Ball, GcMAF, Guernsey, Immuno Biotech
Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm immuno Biotech, that sold unlicensed blood product GcMAF, has been …
Immuno Biotech owner promoting unlicensed ‘cure’ for cancer, autism and HIV to be sentenced next week
November 23, 2018Medical Communications Cancer, David Noakes, GcMAF, HIV, UKIP, autism
The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number …
MHRA shuts down unlicensed cancer drug facility
February 9, 2015Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor
The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
